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Nomenclature
Abbreviations of Chemicals
AAm acrylamide
6-APA 6-aminopenicillanic acid
ATEE N-acetyl tyrosine ethyl ester
bPG benzylpenicillin
CDI carbonyl diimidazole
cis-DE cis-1,2-dimethylcyclohex-4-ene-1,2-dicarboxylate
DCP 2,4-dichlorophenol
DD dodecane
HT hydrotalcite
1-PEA 1-phenylethyl acetate
PAA poly(acrylic acid)
PhAA phenylacetic acid
PAN polyacrylonitrile
PBA poly(normal-butyl acrylate)
PEI polyethyleneimine
PES polyethersulfone
PET poly(ethylene terephthalate)
PFMD perfluoromethyldecalin
PDMS polydimethylsiloxane
POPC 1-palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine
POPS 1-palmitoyl-2-Oleoyl-sn-Glycero-3-Phospho-L-Serine
PS polysulfone
PP polypropylene
PTFE polytetrafluoroethylene
SO silicone oil
T toluene
TG triglycerides
THF tetrahydrofuran
TPP tripolyphosphate
Other abbreviations
EMBR extractive membrane bioreactor
BEMBR biphasic extractive membrane bioreactor
FFMD flow focusing microfluidic device
IEM ion exchange membrane
ILM immobilised liquid membrane
MF microfiltration
MSR membrane separation reactor
UF ultrafiltration
PTC phase-transfer catalysis or catalyst
SC supercritical
VOC volatile organic campound
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2.1 Introduction
The term membrane reactor first began to appear in the chemical engineering litera-
ture around 1980 [1]. Although there is no commonly accepted definition of a mem-
brane reactor, the term usually refers to membrane devices whose function is to per-
form net chemical conversion under conditions in which the unique contacting and
separation features of membranes and membrane devices are exploited. In particu-
lar, the termmembrane reactor is reserved for those processes wherein themembrane
functions as more than simply a reactive membrane, i.e. a membrane matrix used for
catalyst immobilization [1]. The biocatalytic membrane reactor (BMR) is a device in
which biochemical transformations catalyzed by enzymes or cells are combined with
permeation or mass transfer through the membrane.
Since the catalytic efficiency of biochemical systems in vivo can often be attributed
to the action of membrane-bound enzymes, it is not surprising that membrane-aided
biocatalysis using syntheticmembranes is an increasingly popular topic of research in
engineering circles. As noticed by Matson and Quinn [1], any aspects of the structure
and function of biological membranes that have been elucidated over the past several
decadesmake it clear that nature has designed a highly integrated chemical plant that
engineers might profitably mimic.
2.2 Role of membrane in biocatalytic membrane reactors (BMRs)
The most common types of BMRs are summarized in Fig. 2.1. The role of synthetic
membranes in BMRs is to serve: (a) solely as a separation barrier to achieve separa-
tion of the product from a biocatalyst; (b) both as a separation barrier and a medium
for biocatalyst immobilization; (c) as a medium for creating and maintaining high in-
terfacial area per unit volume to conduct non-dispersive gas/liquid and liquid/liquid
mass-transfer processes; and (d) as a medium (carrier) for enzyme or cell encapsula-
tion. If the membrane serves only as a semipermeable barrier, there are two modes
of operations with regard to the location of the biocatalyst in the membrane system:
(i) The biocatalyst is suspended in a stirred tank reactor and the reaction mixture is
continuously brought into contact with the membrane for product removal. In this
mode of operation, the stirred tank functions as a stirred tank reactor (STR); (ii) the
biocatalyst is suspendedonlywithin themembranemodule,where abiochemical con-
version takes place. In the latter case the membrane acts as a medium for biocatalyst
segregation; the membrane module functions as a reactor [2]. If the membrane is a
medium for encapsulation, enzymes or whole cells are entrapped within semiperme-
able micro/nano-particles or vesicles such as liposomes [3], polymersomes [4], col-
loidosomes [5], microgels [6] and polymeric microspheres [7]. Biocatalyst can also be
immobilized in or onto the microporous membrane by physical entrapment [8], gela-
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Fig. 2.1: Classification of biocatalytic membrane reactors (A – substrate, B – water soluble product,◼B◼ – oil-soluble product).
tion [9], physical adsorption [10], ionic binding [11], covalent binding [12] or copoly-
merization [13].
In addition to the typeof immobilization, BMRs canbe classifiedaccording to their
operational mode into ultrafiltration (UF) or microfiltration (MF) membrane reactors,
biphasic (organic and aqueous) membrane reactors, membrane aeration reactors and
extractivemembrane reactors [14]. UFmembrane reactors are usedwhen the substrate
has a significantly higher molecular weight compared to that of the product, and both
substrate and product are soluble in the same solvents. In that case, the substrate
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molecules are transferred to the enzyme immobilized in or onto the membrane, but
they cannot pass through the membrane, whilst the product can freely pass through
and be recovered from the permeate side of the membrane. If the substrate and prod-
uct have a similar molecular size, they can both pass through the membrane. In that
case, the membrane type and operating conditions should be chosen in such a way
that the permeation rate matches the reaction rate to ensure that the substrate will be
fully converted into the product as it passes through the membrane. If the substrate
has a different solubility to the product (e.g. an oil-soluble ester and its water-soluble
hydrolysis products), a biphasic membrane reactor might be a good choice [15]. In
this type of reactor system, the enzyme-loaded membrane is located between two im-
miscible liquid phases, an organic and an aqueous phase. The organic phase, which
contains the substrate, circulates on one side of the membrane; the substrate is dif-
fused to the hydrophilic membrane wetted by the aqueous phase, where the reaction
takes place in an aqueous environment, and the product is extracted by the aqueous
phase circulated on the other side of the membrane. If the biocatalyst is selective for
only one of the two enantiomers present in a racemic mixture, a biphasic system is
particularly useful for production of pure enantiomers [16]. Pure isomers are required
in biomedical applications, where they have to be administered to humans and ani-
mals.
The membrane in BMRs may also serve as a medium for a bubbleless transfer
of gas (oxygen or air) into a bioreactor to augment microbial degradation [17] or as a
medium for a non-dispersive extraction of organic pollutants from wastewater [18].
Another classification of membrane reactors is based on the relative position of
the two most important elements of the reactor: the membrane and the catalyst. The
threemain configurations are shown in Fig. 2.2: (a) the catalyst is suspended in a reac-
tion mixture separated from the membrane; (b) the catalyst is suspended in a liquid
core which is surrounded by the membrane (a core-shell microcapsule); and (c) the
catalyst is incorporated within the membrane, i.e. the membrane is inherently cat-
alytic. The membrane in core-shell microcapsules can be composed of lipid bilayers,
a hydrogel, synthetic polymer, fused particles, etc. Hybrid systems are also possible,
for example the matrix-type porous microcapsule shown in Fig. 2.2 (d) combines the
structures shown in Fig. 2.2 (b) and (c). Although membranes are more expansive as
enzyme supports than porous beads shown in Fig. 2.2 (b) and (d), their advantages
may in many applications overcome this limitation (Tab. 2.1). Membranes permit a
much higher order and generally smaller scale of organization than do particles [1].
The fluids on either side of a membrane can be separated by appropriate membrane
module design; this then provides the engineer with an additional degree of freedom
in reactor design. While there is only a single interface between a porous catalyst par-
ticle and the solution surrounding it (Fig. 2.2 (d)), two membrane/solution interfaces
and two liquid compartments exist that can be exploited in a number of ways. For
example, a membrane reactor might be used to catalyze the reaction between two re-
actants present in separate streams that cannot be mixed for some reason, perhaps to
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avoid a subsequent separationproblemor anon-catalytic side reaction, or reactants or
products are soluble in different solvents (organic and aqueous). When porous beads
are used, separation of the products from the reactants is impossible because there is
only one liquid compartment. For the same reason, the product concentration in the
porous beads reactor is limited by the stoichiometry of the reaction, conversion and
reactant concentrations. When a catalyst is encapsulated within a porous membrane,
the product concentration can be controlled by the flow rate ratio of the product and
feed stream, whichmakes it possible to achieve high product concentrations irrespec-
tive of the reactant concentration. In addition, the rate ofmass transferwithin aporous
membrane can be enhanced by creating a pressure difference across the membrane,
which will lead to convective transport of species across the membrane. On the other
hand, within a porous bead, mass transfer can only occur by molecular diffusion.
Tab. 2.1: Comparison of porous membranes and porous particles as enzyme supports.
Function Type of catalyst support
Membrane Porous particles
or capsules
Immobilization Yes Yes
Mass transfer by diffusion Yes Yes
Mass transfer by convection Yes No
Liquid/liquid separation Yes No
Enzyme/product separation Yes No
Product concentration Yes No
Membrane Matrix
Single
interface
(a)
Membrane
(b) (d)
Membrane
Interface 1
(c)
Interface 2
Fig. 2.2: Typical configurations of membrane biocatalytic reactors according to the relative posi-
tion of the membrane and the catalyst: (a) the catalyst is physically separated from the membrane;
(b) the catalyst is encapsulated in a core-shell microcapsule; (c) the catalyst is incorporated within
the membrane wall; (d) the catalyst is encapsulated in a matrix-type microcapsule.
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Fig. 2.3: Typical biocatalytic membrane reactor systems based on configurations shown in Fig. 2.2:
(a) Stirred tank reactor combined with membrane module for enzyme recycle and product with-
drawal; (b) Stirred tank with enzymes entrapped within core-shell microcapsules; (c) Stirred tank
with enzymes immobilized within the membrane matrix.
Fig. 2.3 shows typical BMRs based on the configurations presented in Fig. 2.2. The BMR
shown in Fig. 2.3 (a) consists of a continuous stirred tank reactor combinedwith an ul-
trafiltration (UF) or microfiltration (MF) membrane module for the product removal.
The reactor presented in Fig. 2.2 (b) is a conventional stirred tank reactor in which
biocatalysts are encapsulated within microcapsules with semi-permeable walls. In a
membrane immobilization approach shown in Fig. 2.3 (c), enzymes are bound to the
membrane by physical adsorption, gel formation, electrostatic deposition or covalent
attachment. Substrates are transferred across the membrane wall to the catalyst and
the products diffuse from the reaction site to the other side of the membrane; they
are recovered here as a permeate. In general, it is the mass-transport resistance that
primarily influences the performance of these reaction systems. In order for a reactor
to function at its optimal performance, it should work in a reaction-limited regime
rather than a diffusion-limited regime. The parameter that can give a measure of this
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condition is the Thiele modulus, which is given by:
ϕ = L ( rmaxDeffKm )
1/2
, (2.1)
where L is the length, rmax is the maximum reaction rate, Km is the Michaelis-Menten
constant and Deff is the effective diffusivity. This has the physical meaning of a ratio
between the reaction rate and the diffusion rate. For ϕ ≤ 1, the system is essentially
controlled by chemical kinetics and the mass-transfer limitation is negligible [19].
2.3 Membrane separation reactors (MSRs)
2.3.1 Concept
A membrane separation reactor (MSR) can be considered as a combination of a re-
action vessel, either a continuous stirred tank reactor (CSTR) or a batch stirred tank
reactor, and a membrane module. The purpose of the membrane is to contain a dis-
solved or dispersed biocatalyst (enzyme molecules or cells) in the reaction vessel,
while products and unreacted permeable reactants are allowed to leave the reactor. In
a continuous flow process, the solution is supplied continuously to the vessel, while
the product, together with excess solvent, is withdrawn in a feed-and-bleed operation
[14, 20, 21]. The process results in the product removal without a loss of the biocatalyst
and high-molecular weight substrate. The biocatalytic reaction usually occurs in an
aqueous phase, although organic solvents or supercritical CO2 (SC CO2) could bemore
appropriatemedium thanwater for conversion of hydrophobic substrates [22, 23]. The
advantages of using SC CO2 over organic solvents include environmental, health and
safety, and process benefits. The use of SC CO2 can allow higher mass transfer rates
because of the lower viscosity of SC CO2 compared to that of organic solvents and ac-
companying high molecular diffusivities. On the other hand, the problemwhen using
biocatalysts in SC CO2 is that high pressure, lawwater activity, increased temperature,
and pressurization/depressurization steps may adversely affect the catalyst stability
and activity.
The main advantages of MSRs over conventional biocatalytic reactors are pro-
longed biocatalyst activity, reduction in costs and energy due to biocatalyst recycling,
greater yields and selectivities due to continual removal of products, higher capacity at
the same reactor volume due to high biocatalyst loadings, and simple scale-up to large
systems due to modular design of membrane units. In addition, the product stream is
typically free from all suspended matter including bacteria and viruses [24]. Along
with the complete removal of bacteria and viruses, MSRs are compact devices with a
smaller footprint than conventional biocatalytic systems, since they can achieve si-
multaneous bioconversion, separation and concentration in a single unit.
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Fig. 2.4: Different modes of operation of membrane separation reactors: (a) External membrane
loop (‘sidestream’); (b) Internal membrane (‘submerged’); (c) segregation in a single-set hollow fiber
module; (d) segregation in a two-set hollow fiber module.
The separation of low-molecular-weight products from biocatalysts can be achiev-
ed using either an external loop with a separate membrane module (Fig. 2.4 (a)) or a
membrane submerged inside the reaction vessel (Fig. 2.4 (b)) [25, 26]. In the set-up il-
lustrated in Fig. 2.4 (a), the content of the vessel is circulated continuously through the
externalmembranemodulewhere an enzyme-free permeate is removed from the reac-
tion mixture. The submerged system differs in that there is no recirculation loop and
the separation occurs within the bioreactor. In either case, surface shear and/or back-
flushing is applied to control cake formation and fouling. In the submerged system,
the membrane is mounted in the stirred tank; stirring or bubbling is usually applied
to produce the surface shear and the permeate is removed by suction with a vacuum
pump or by a compressed gas. The membranes used in the submerged systems are
typically hollow fibers or flat sheets, aligned vertically or horizontally. When the sur-
face shear is provided by bubbling, gas is introduced below the membrane assembly
and is distributed to optimize the air scouring action across the vertical membrane
surface. The two methods based on internal or external membranes in conjunction
with the reaction vessel both have their advantages and drawbacks. The external loop
membrane can easily be changed if severe clogging occurs. Furthermore, in the ex-
ternal membrane loop it is easier to increase the filtration area if necessary. On the
other hand, when operating with high biocatalyst densities using an external loop,
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there is a risk of the occurrence of oxygen limitation. One way to reduce this risk is to
increase the rate of circulation through the membrane module, but high shear stress
can damage shear-sensitive biocatalysts.
One option to prevent damages to shear-sensitive cells and enzymes is to segre-
gate a biocatalyst within a hollow fiber membrane module. In the system shown in
Fig. 2.4 (c), the feed stream is introduced through the lumen of the fibers and biocat-
alysts are localized in the extra-capillary space, where the reaction proceeds in a low
shear-stress environment. Substrate molecules diffuse through the walls of the fibers
from inside to outside and the products diffuse in the opposite direction. A transverse
flow hollow fiber module containing two independent sets of hollow fibers placed
within the same frame element (Fig. 2.4 (d)) is a potential alternative to the conven-
tional parallel flowmodule, suitable tomeet very high oxygen demands in the reactor.
In this case, substrate is fed and products are removed via the lumen of one set of hol-
low fibers and oxygen is supplied through the lumen of the second set of the fibers,
while the biocatalyst is dispersed in the extra-capillary space. An additional advan-
tage of this design is that the membrane area can easily be increased by adding more
frame elements, similar to a plate-and-frame-filter press [27].
The main benefits of using MSRs are schematically shown in Fig. 2.5 [28].
(a) Increase of conversion in reversible reactions: the major role of the membrane
here is to selectively remove a product of a reversible reaction from the reaction
mixture (product C in Fig. 2.5 (a), thereby shifting the equilibrium towards higher
product yields (i.e. higher conversions of A). The reactions of this type include
dehydrogenation and esterification reactions.
(b) Enhancement of selectivity through controlled product removal: the role of the
membrane in Fig. 2.5 (b) is to suppress the further decomposition of a desirable
intermediate product (C) by removing this product through the membrane.
(c) Enhancement of selectivity through controlled addition of reactants: in this ap-
proach, the concentration of a reactantB in the reactionmixture (A+B) is kept low
by a controlled supply of B through the membrane, so that the rate of formation
of a by-product D is kept low (Fig. 2.5 (c)). Controlled addition can also be useful
to prevent catalyst deactivation and to avoid a dangerous increase of temperature
in exothermic reactions. Partial oxidation of hydrocarbons is the most relevant
application of this approach where a controlled addition of the oxidant through
the membrane results in a better yield of the intermediate oxidation products.
A         B + C
C
(a) (b) (c)
A + B     C + B     D
A + B     C
A + nB    D
B
C
Fig. 2.5: Major benefits of using membrane reactors: (a) improved conversion; (b), (c) increased
selectivity.
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2.3.2 Application
A number of nutritionally important amino acids have been synthesized or optically
resolved on an industrial scale using enzymatic reactions in membrane separation
reactors [1]. Wichmann et al. [29] have conductedmultienzyme (multistep) bioconver-
sionswith simultaneous cofactor regeneration in a continuously operatedMSR shown
in Fig. 2.6. For the continuous operation of cofactor dependent systems, it is critically
important to retain and regenerate the cofactor in the reaction mixture. The reten-
tion of native cofactors such as NAD/NADH by a membrane would require a reverse
osmosis membrane that has a very low permeability to water as compared to an UF
membrane. Moreover, it would be difficult, if not impossible, to obtain the product
without leakage of the cofactor through the membrane, due to the small difference
in size between the solvent and the cofactor molecules. This problem was solved by
enlarging the cofactor molecule to a size similar to that of the enzyme. It was achieved
by covalent attachment of the cofactor (NAD+/NADH) to poly(ethylene glycol) (PEG), a
linear polymer with only two terminal reactive groups on the polymer chain, so steric
hindrance was low [29]. The PEGylated cofactor was used to catalyze the reductive
amination of α-ketoisocaproate by L-leucine dehydrogenase (enzyme E2 in Fig. 2.6) to
L-leucine. Formate dehydrogenase (enzyme E1 in Fig. 2.6) was used for regeneration
of NAD+ from NADH. The use of charged UF membranes is an alternative method for
the retention of the native coenzyme NADH in a membrane reactor [30].
HCOO–
(     )
(     )
(     )
(     ) (     )(     )
(     )
(     )
NAD+ L-Amino acid
+ H2O
+ NH4
α-Keto acidNADHCO2
E1 E2
Fig. 2.6: Membrane separation reactor for con-
tinuous enzymatic synthesis of L-amino acid
from α-keto acid with coenzyme (NADH/NAD+)
regeneration. Adopted from [29].
In addition to the synthesis reactions, membrane reactors are extensively used in the
enzymatic hydrolysis of natural macromolecules (starch, cellulose, proteins, pectin,
chitosan, etc.), oligo- anddi-saccharides, andbioflavonoids, especially for biomedical
and pharmaceutical applications (Tab. 2.2) and in the agro-food sector (Tab. 2.3).
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Tab. 2.2: Examples of medical and pharmaceutical applications of membrane reactors (CO = cut-off).
Enzyme or cells Membrane Reaction Purpose Reference
Arginase,
asparaginase
Hemophan
(cellulose
derivative)
Hydrolysis of
arginine and
asparagines
Cancer therapy Shettigar [31]
Heparinase,
tripsin, pronase
Polyester
membrane
Hydrolysis of
blood toxins,
such as heparin
Removal of
blood toxins
in hemodialasys
Ameer et al. [32]
Hepatocytes Hollow fiber or
flat plate
Liver-specific
functions
Extracorporeal
bioartificial liver
devices
Allen et al. [33]
2001
Pancreatic
endocrine cells
Nucleopore,
pore size = 0.1 μm
Insulin secretion Bioartificial
pancreas
Ohgawara et al.
[34]
Bacterial
protease
PES, CO = 3 kDa Hydrolysis of
whey proteins
Production of
low allergenicity
hydrolysates for
enteral nutrition
Guadix et al. [35]
Amidase from
Microbacterium
imperiale
Fluoropolymer,
CO = 20 kDa
Deamidation of
nicotinamide to
nicotinic acid
Production of
nicotinic acid (B-
complex vitamin)
Cantarella et al.
[36]
Glucose-fructose
oxidoreductase
from Zymomonas
Mobilis
Milipore,
CO = 10 kDa
oxidation of
glucose
Production of
lactobionic acid
for medical use
Satory et al. [37]
More recently, membrane reactors have been used successfully for the treatment of
wastewaters. The constantly increasing degree of industrialization and urbanization,
rising standards of living, increasing population growth and agricultural activities are
strongly impacting on the use of available water sources and on the quality of water
that is found therein. This exhaustive use of limited resources and energy by modern
society implies a need for changes in present and future urban water and wastewater
treatment systems [51]. Membrane reactors enable degradation but also the recupera-
tion of valuable components from effluent streams (Tab. 2.4). They are also useful for
reusing contaminated process water [60, 61].
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Tab. 2.3: Examples of agro-food applications of membrane reactors (CO = cut-off).
Enzyme Membrane Reaction Purpose Reference
Trypsin from
bovine pancreas
Cellulose ace-
tate, CO = 3 kDa
Hydrolysis
of caseino-
macropeptide
Production of
peptides for
functional food
Prata-Vidal et al.
[38]
Trypsin from
bovine pancreas
Cerasep®
nanofiltration
Hydrolysis
of caseino-
macropeptide
Production of
peptides for
functional food
Martin-Orue
et al. [39]
Enzymes from
Trichoderma
reesei fungi
Carbosep® M5,
CO = 10 kDa
Hydrolysis of
olive mill solid
residue
Ethanol produc-
tion
Mameri et al.
[40]
Glucoamylase
from Aspergillus
niger
Amicon Diaflo®
H1510-43,
CO = 10 kDa
Hydrolysis of
cassava flour
starch
Production of
pure dextrose,
high fructose
syrups, etc.
López-Ulibarri
and Hall [41]
Glucoamylase regenerated
cellulose,
CO = 10 kDa
Hydrolysis of
corn starch
Production of
glucose or mal-
tose syrups
Singh and
Cheryan [42]
β-Galacto-
sidase from
Kluyveromyces
fragilis
Cuprophan® and
PS hollow fiber,
CO = 5 kDa
Hydrolysis of
lactose
Milk or whey
delactosization
Jurado et al. [43]
naringinase from
Aspergillus niger
Romicon HF
1.1-43-PM10
Hydrolysis of
naringin
Debittering of
grapefruit juice
Gray and Olson
[44]
polygalacturo-
nase from
Aspergillus niger
regenerated
cellulose,
CO = 30 kDa
Hydrolysis of
pectin
Clarification of
fruit juice
Bélafi-Bakó et al.
[45]
polygalacturo-
nase from
Aspergillus niger
polysulfone,
CO = 10 and
50 kDa
Hydrolysis of
pectin
Clarification
of wine and fruit
juice
Rodriguez-
Nogales et al.
[46]
Invertase im-
mobilised on
polystyrene
beads
regenerated
cellulose,
CO = 100 kDa
or 5 μm
Hydrolysis of
sucrose
Production
of high-fructose
syrup
Tomotani and
Vitolo [47]
xylose reductase
from Candida
tenuis
Nitto NTR 7430,
CO = 1 kDa
Reduction of
xylose to xylitol
Production of
xylitol, a natural
food sweetener
Nidetzky et al.
[48]
chitosanases
and chitinase
from Bacillus
cereus
Amicon Diaflo®
H1510-43,
CO = 10 kDa
Hydrolysis of
chitosan
Production
of chitooligo-
saccharides
Kuo et al. [49]
Pronase from
Streptomyces
griseus
Amicon
Diaflo® H1510,
CO = 10 kDa
Hydrolysis of soy
protein isolate
Production
of soy protein
hydrolysates for
functional food
Deeslie and
Cheryan [50]
2.3 Membrane separation reactors (MSRs) | 63
Tab. 2.4: Examples of applications of membrane reactors to the wastewater treatment.
Enzyme Source Reactor Membrane Application Reference
Immobilized enzyme membrane reactor
Crude en-
zyme extract
Pseudo-
monas sp.
Batch UF cell Flat poly-
acrylonitrile
Phenolic
effluent
Bohdziewicz
[8], Bodzek
[52]
Polyphenol
oxidase
(EC 1.14.18.1)
Agaricus
bisporum
Hollow fiber
membrane
reactor
Polysulphone Coal-gas con-
version plant
effluents
(phenols)
Edwards
et al. [53]
Laccasse
(EC 1.10.3.2)
Pyricularia
oryzae
Spiral-wound
module
Polyether-
sulphone
Synthetic
industrial
wastewater
(phenols)
Lante et al.
[54]
Laccasse Trametes
versicolor
Frame plate
reactor mod-
ule
Modified
polyvinyl-
idene di-
fluoride
(PVDF)
Herbicide
N󸀠,N󸀠-
(dimethyl)-
N-(2-hydroxy-
phenyl) urea
(2-HF)
Jolivalt et al.
[55]
Extractive membrane bioreactor
Glucose
oxidase
Aspergilus
Niger
Hollow fiber Polyether-
sulphone
Synthetic
industrial
wastewater
(glucose)
Kojima et al.
[56]
Glycerol
dehydro-
genase
Enterobacter
aerogenes
Stirred tank
reactor and
hollow fiber
Polyether-
sulphone and
hydrophobic
membrane
Ethanol oxi-
dation
Liese et al.
[57]
Membrane separation reactor
Soybean
peroxidase
Ground
soybean
seed-hulls
Stirred tank
reactor
— Synthetic
industrial
wastewater
(phenols)
Flock et al.
[58]
Pectolyase Aspergilus
japonicus
Stirred tank
reactor
Polyether-
sulphone
Depoly-
merization
of polygalac-
turonic acid
Gallifuoco
et al. [59]
Manganese
peroxidase
Bjerkandera
sp.
Stirred tank
reactor
Polyether-
sulphone
Dye decol-
orization
López et al.
[20]
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2.4 Membrane aeration bioreactors (MABR)
A basic requirement for the aerobic degradation of organic material is oxygen, which
is required to support the life and growth of themicrobes performing the degradation.
It is therefore imperative that these systems receive sufficient oxygen as, without it, a
rapid deterioration in the quality of effluent will occur [62]. The rate of oxygen mass
transfer can be greatly improved by using high purity oxygen rather than atmospheric
air (approximately by a factor of 5), but these oxygenation devices require a great deal
of power in order to efficiently mix the gas into the solution and obtain a high oxygen
transfer efficiency; they thus cannot be used in conjunction with biofilm processes
in which the reactor should remain static [20]. The membrane aeration bioreactor
(MABR) concept was developed in response to the need for increased oxygen mass
transfer into wastewaters in cases where the oxygen requirements for degradation of
the pollutant were too high for conventional aeration processes. It is also applicable
when the bubbling of air can result in either stripping of volatile organic compounds
(VOCs) [63], foaming [17] of industrial wastewaters or the damage to shear-sensitive
cell cultures [64]. The membrane itself can play a dual role in the reactor, namely as a
means for supplying oxygen and a substrate for biofilm formation.
Fig. 2.7 is a schematic diagram outlining the principle of the MABR. A membrane
(dense gas permeable, microporous or composite, i.e. microporous coatedwith a non-
porous gas permeable) is used to transfer oxygen to the bacteria present in the bioreac-
torwithout formingbubbles andwith 100%oxygen transfer efficiency. Themembrane
also acts as a support for biofilmgrowth.Wastewater flowsover the outer surface of the
biofilm and counter-diffusion of oxygen and pollutant occurs, as shown in Fig. 2.7 (a).
Oxygen transferred through themembrane is utilized in the degradation of pollutants
in the biofilm. MABRs have been use to treat a wide variety of wastewater types and
have been shown to beparticularly effective in treatinghigh oxygendemandingwaste-
waters [65], biodegradation of VOCs [66, 67], combined nitrification, denitrification
and/or organic carbon degradation in a single biofilm [68, 69]. When a MABR system
is used for the treatment of waste vapor streams, volatile organic compounds (VOCs)
and oxygen are transferred concurrently through the membrane to the biofilm and
a liquid phase flowing on the opposite side of the membrane is a source of mineral
salts for the culture growth. The most commonly used membranes for MABRs are
silicon rubber tubing [70] and microporous polypropylene hollow fiber membranes
[67]. For the biotreatment of vapor streams containing aromatic contaminants, the
nonporous silicone membrane system delivered superior performance over the mi-
croporous membrane system in terms of surface-area-based removal rates, long-term
operational stability and maintenance [67].
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Fig. 2.7: Schematic diagram of the MABR system utilizing a hydrophobic microporous membrane:
(a) biodegradation of organics from a wastewater stream; (b) removal of VOCs from a waste vapor
stream.
2.5 Extractive membrane bioreactors (EMBR)
2.5.1 Concept
The principle of an EMBR is illustrated in Fig. 2.8. An aqueous feed stream (usually
wastewater) containing the organic compound(s) to be degraded is passed over one
surface of a nonporous semipermeablemembrane, while a biocatalyst (usuallymicro-
bial culture) is maintained in an oxygenated aqueous biomedium at the other surface.
The pH and ionic strength of the wastewater have no influence on the makeup of the
biomedium as the membrane is impermeable to any inorganic or charged species in
the wastewater. Thus the biomedium composition can be controlled and optimized
independently of the composition of the wastewater to provide optimal growth con-
ditions for the microbial culture in spite of the biologically hostile makeup of the
wastewater [71]. The driving force for the mass transfer across the membrane is the
Membrane
Suspended
biomass
BiofilmAqueous stream
containing inorganic
and organic species
Exiting stream
containing only
inorganic species
Organics
Fig. 2.8: Schematic diagram of the EMBR
process. Organic pollutants selectively diffuse
through the nonporous membrane material
into the biomedium phase where they are
biodegraded in the biofilm.
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concentration difference between the organic pollutant in the wastewater and in the
biomedium, which is maintained by biological degradation.
The EMBR systems are usually composed of silicone rubber (polydimethylsilox-
ane) tubing or plates. The pilot unit, schematically represented in Fig. 2.9, consists of
two membrane modules, each with eight coils of silicone tubing linked in series and
submerged in a reactor fitted with a mechanical stirrer. Wastewater was fed through
the membrane tubes. Air was bubbled through the reactor to maintain the dissolved
oxygen concentration at the optimum level. Low pressure steam was fed directly into
the reactor tank to maintain temperature at around 30 °C. pH was controlled by the
automatic dosing of either sulphuric acid or sodium hydroxide solution.
Acid or base
dosing
pH
control
Outlet wastewater Wastewatertank
Nutrient
tank
Membrane
tube
Steam
Air
Biomedium
overflow
Bioreactor
Fig. 2.9: Schematic diagram of the pilot-scale EMBR unit [18].
Due to bacterial attachment, a membrane-attached biofilm forms on the shell side
of the membrane. A thin biofilm (200–400 μm) is advantageous because it limits
the air stripping of volatile organic compounds [72]. However, an increase in biofilm
thickness results in a decrease in organic pollutant(s) flux across the membrane.
The EMBR shares this problem with membrane aeration reactors, where membrane-
attached biofilms also create mass transfer limitations [73, 74]. It was confirmed by
mathematical modeling of biofilm growth in an EMBR that due to the limited solu-
bility of oxygen in water, oxygen could only penetrate thin biofilms [75]. Therefore,
the active layer is very close to the biofilm/biomedium interface. Consequently, an
inverse relationship between the organic flux and biofilm thickness was observed.
Several modifications have been attempted to suppress themetabolism of the biofilm-
forming bacteria, such as addition of sodium chloride [76], increasing the shear stress
on themembrane surface [77], using a biphasic system [78] and the addition of nitrate
as an electron acceptor instead of oxygen [79]. Nitrate is highly soluble in water and
therefore, the nitrate concentration in the biomedium can be sufficiently high to fully
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penetrate the biofilm, ensuring that nitrate is present at the biofilm/membrane inter-
face. Theoretically, the substrate could then be biodegraded at the biofilm/membrane
interface, alleviating the decrease in pollutant flux with biofilm growth. Another
approach is based on the modification of the interfacial properties that regulate mi-
crobial attachment to the membrane through addition of surfactants [80].
2.5.2 Application
EMBR was used for degradation of organic pollutants and solvents from synthetic
and industrial wastewaters. More than 99% of 1,2-dichloroethane (1,2-DCA) was
removed from a synthetic wastewater containing 1600mg l−1 of 1,2-DCA [63]. 2,4-di-
chlorophenoxyacetic acid, a component of commercial herbicides, has also been
successfully degraded at laboratory scale using a suitably acclimated microbial cul-
ture [81]. In addition, toluene and dichloromethane, the two most commonly used
solvents in the chemical and pharmaceutical industries, were being degraded by a
commensal microbial culture [82].
When EMBR was used with industrial wastewaters, the results were also encour-
aging. Wastewater from a 3-chloronitrobenzene-manufacture plant was successfully
remediated with the removal efficiencies of greater than 99% at residence times
of ~ 30min [83]. Brookes and Livingston [84, 85] operated a laboratory-scale reac-
tor continuously for 5months and consistently removed aniline, 4-chloroaniline,
2,3-dichloroaniline and 3,4-dichloroaniline at efficiencies greater than 99%. Conven-
tional direct biological treatment of such effluents cannot be implemented without
pretreatment or dilution because of the hostile inorganic composition of the waste-
water. Other examples of successful application include the removal and degradation
of compounds such as monochlorobenzene, where 98 to 99% of the pollutant was
destroyed at a flow rate of 50 l/h [71], 1,2-dichloroethane (94.5% removal) with negli-
gible air stripping [63] and various other chemical and pharmaceutical waste streams
with similar results. Particularly, the EMBR system is suitable for the treatment of
wastewaters in which a recalcitrant hydrophobic toxic compound is mixed with high
concentrations of an easily biodegradable hydrophilic compound. Biodegradation of
such wastewaters is difficult in conventional bioreactors, since the microbial cultures
tend to grow on the easily biodegradable compound in preference to the toxic com-
pounds. An example of this type of wastewater is the industrial wastewater produced
from a hydrogenation process that contains ◼◼ g l−1 concentrations of toluidines such Note 7: Miss-
ing value?as 3-chloro-4-methylaniline and methylammines (which are hydrophobic and not
easily biodegradable) and up to 2–3 vol% of methanol (which is hydrophilic and
easily biodegradable) [18]. The EMBR technology is suitable for treating this kind
of waste, since the hydrophobic target compounds can rapidly cross the membrane
and be degraded in the bioreactor, whilst the hydrophilic methanol is retained in the
EMBR effluent and goes on to further treatment.
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A number of variations of the basic EMBR configuration have been attempted.
Splendiani et al. [78] have developed the biphasic extractive membrane bioreactor
(BEMBR) in which biofilm accumulation was controlled by preventing direct contact
between microorganisms and the membrane. In BEMBR systems, the two main con-
stituents of the process, membrane and bacteria, are kept separated and interact via
a suitable recirculating solvent, as shown in Fig. 2.10. The BEMBR system consists
of a biphasic bioreactor and a membrane module with a silicone rubber tube fitted
coaxially in a cylindrical shell. The nonporous membrane selectively extracts the or-
ganic pollutants from the waste streams. On the shell side, the pollutants are des-
orbed into the organic solvent, which is re-circulated between the membrane mod-
ule and the bioreactor. In the bioreactor, the pollutant-rich solvent is mixed with the
aqueous biomedium, and the pollutants are transferred from the solvent to the aque-
ous biomedium where they are metabolized by suspended bacteria. The lean solvent
is continuously separated from the aqueous biomedium and recycled back into the
membrane shell. The organic solvent must not be toxic for bacteria or inhibit the pol-
lutantmetabolization; it must not be utilized by bacteria as a source of carbon and en-
ergy – itmust exhibit lowmicrobial adhesivity, lowmembrane swelling and emulsion-
forming tendency. According to Splendiani et al. [78], the solvent that best satisfies
these requirements is perfluoromethyldecalin (PFMD). They tested the BEMBR sys-
tem with PFMD as a solvent for degradation of monochlorobenzene using a synthetic
wastewater. The systemwas operated over a one-month periodwith negligible biofilm
accumulation. Throughout the period of operation, the overall mass transfer coeffi-
cient remained stable at approximately the value obtained for mass transfer through
the bare membrane.
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Fig. 2.10: Schematic diagram of the biphasic EMBR process [78].
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Liu et al. [86, 87] coupledEMBRwith the conventional solvent extraction and stripping
to degrade chlorophenolic compounds to levels lower than 100mg l−1. The process
was operated in four units shown inFig. 2.11: (1)Extraction unit. The acidic organic pol-
lutant in the acidic wastewater (stream a, containing 1000mg l−1 2,4-dichlorophenol
(DCP), and 5% NaCl at pH < 1) is extracted by a water insoluble organic solvent. The
raffinate is discharged after filtering through a hydrophilic microfiltration membrane
thatminimizes loss of organics in droplet form (stream b, containing < 100mg l−1 DCP
and 5% NaCl at pH < 1). (2) Stripping unit. The extract is pumped from the extraction
unit to the stripping unit where organic pollutant is transferred into an alkaline aque-
ous phase and its concentration in the raffinate out of the stripping unit (stream c)
is much higher than that in the treated water (stream b). (3) Membrane separation of
O/W emulsion and biomass. Organic droplets in the raffinate from the stripping unit
(stream c) are filtered out by the hydrophilic ceramicmembrane, thus the organic pol-
lutant is fed into the bioreactor but not the solvent droplets. The outlet stream of the
bioreactor is filtered from the reverse direction in a secondmembrane for the purpose
of removing the reaction products while retaining the biocatalysts. These units are
periodically switched in function. After the switch the filtration of biomass separation
serves to backflush the membrane previously used for filtering the O/W emulsion and
vice versa. In this way, membrane fouling is reduced. (4) Bioreactor. The organic pol-
lutant is fed to the bioreactor as the carbon and energy source for the bacteria andmay
be supplied to be present at optimum concentrations and suitable pH and tempera-
ture.When the pollutants are chlorinated hydrocarbons, hydrochloric acid is released
as the biodegradation by-product. The hydroxide ion present in the stripping solution
is consumed to neutralize the hydrochloric acid.
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Treated water
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Biomass
filtration
Biocatalyst
Bioreactor
Solvent
recirculation
KOH O/W emulsion
filtration
Extraction (pH<1)
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Fig. 2.11: Schematic diagram of the hybrid EMBR process, combining conventional liquid-liquid
extraction cycle and a membrane bioreactor [86, 87].
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2.6 Enzyme immobilization techniques in membrane
reactor systems
Immobilization is a very powerful tool to improve almost all properties of biocata-
lysts (enzymes and whole cells) such as stability, activity, specificity and selectivity
[88]. Immobilization also simplifies the separation of reaction products from catalysts
and facilitates the recovery and reuse of catalysts, which frequently is too expensive
for one-time use. Many approaches exist for the immobilization of enzymes in micro-
porous membranes, as illustrated in Fig. 2.12. Enzymes can be covalently bound or
cross-linked within porous membranes, attached to a membrane surface by physical
adsorption or ionic binding, entrapped within the porous substructure of asymmetric
membranes, encapsulated in microporous beads or particles and segregated (local-
ized) between two sets of hollow fiber membrane or two sheets of flat membrane [89].
The examples of enzyme immobilization techniques in membrane reactors are listed
in Tab. 2.5.
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Fig. 2.12: Schematic representations of enzyme immobilization techniques in membrane reactors,
where M = membrane and E = enzyme.
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Tab. 2.5: Examples of enzyme immobilization techniques in membrane reactors (CO = cut-off).
Enzyme Membrane Reaction Immobilization
method
Reactor Reference
Pig liver es-
terase
polyamide
hollow fibers
Stereo-
selective
hydrolysis
of cis-DE
Covalent bind-
ing, physical
entrapment
Multiphase Sousa et al.
[12]
lipase from
Pseudomonas
Polyamide
hollow fibers
Stereo-
selective
hydrolysis
of 1-PEA
Covalent bind-
ing
Multiphase Ceynowa and
Koter [90]
lipase from
Candida cylin-
dracea
PAN hollow
fibers
Stereo-
selective
hydrolysis
of MMPG
Physical en-
trapment
Multiphase Lopez et al.
[91]
lipase from
Candida
rugosa or
Pseudomonas
cepacia
PAN and PES
hollow fibers
Stereo-
selective
hydrolysis
of naproxen
methyl ester
Physical en-
trapment
Multiphase Sakaki et al.
[16]
bovine liver
catalyse
Cellulose
acetate hollow
fibers
blood oxygena-
tion
Covalent bind-
ing
MSR Cioci et al. [92]
Fructosime L
(inulinases
from Asper-
gillus niger)
PS hollow
fibers
Hydrolysis of
inulin
Physical ad-
sorption
MSR Díaz et al. [93]
Lipase from
Candida cylin-
dracea
PP hollow
fibers
Hydrolysis of
olive oil
Physical ad-
sorption
Multiphase Hoq et al. [94]
Cellulase from
Humicola
insolens
Polymer-
coated ceramic
membrane
Hydrolysis of
carboxy-methyl
cellulose
Covalent bind-
ing
High-pressure
with SC CO2
Habulin et al.
[23]
fructosyl-
transferase of
Streptococcus
mutans
Nanoparticle
composite PET
membrane
Synthesis of
poly-β-(2-1)-
fructan (inulin)
Covalent bind-
ing
MSR Hicke et al.
[95]
Chymotrypsin,
α-amylase,
thermo-
amylase,
amino-acid
ester hydro-
lase
Silica modified
PVC membrane
Hydrolysis
of DL-Trypto-
phane methyl
ester, starch,
and DL-pheGly
methyl ester
Physical en-
trapment
followed by
cross linking
the enzyme
MSR Simon [13]
Lipase from
Candida ru-
gosa
Hydrophilic
PAN mem-
brane,
CO = 50 kDa
Stereo-
selective
hydrolysis
of ibuprofen
methyl ester
Physical en-
trapment
Multiphase Long et al. [96]
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2.6.1 Physical adsorption
The method relies on non-specific physical interaction between the enzyme protein
and the surface of themembrane, brought about bymixing a concentrated solution of
enzyme over themembrane in stirred cells or by recirculating a concentration solution
along the membrane. A major advantage of adsorption as a method of immobiliz-
ing enzymes is that usually no reagents and only a minimum of activation steps are
required. As a result, adsorption is cheap, easily carried out, and tends to be less
disruptive to the enzymic protein than chemical means of attachment, the binding
beingmainly performedbyhydrogen bonds,multiple salt linkages andVanderWaal’s
forces. In this respect, the method bears the greatest similarity to the situation found
in biological membranes in vivo and has been used to model such systems. Because
of the weak bonds involved, desorption of the protein resulting from changes in tem-
perature, pH, ionic strength or even themere presence of substrate, is often observed.
Another disadvantage is non-specific further adsorption of other substances as the im-
mobilized enzyme is used. Thismay alter the properties of the immobilized enzyme or,
if the substance adsorbed is a substrate for the enzyme, the ratewill probably decrease
depending on the surfacemobility of enzyme and substrate. Adsorption of the enzyme
may be necessary to facilitate the covalent reactions described later. Stabilization of
enzymes temporarily adsorbed onto a membrane matrix has been achieved by cross-
linking the protein in a chemical reaction subsequent to its physical adsorption.
2.6.2 Entrapment
Matson [97] has developed an enzyme immobilization technique in which the enzyme
is contained in an asymmetric or compositemembrane between two immiscible liquid
streams. This type of immobilization is common in multiphase hollow-fiber reactors
described in details in Section 2.8. Initially, an aqueous enzyme solution is charged to
the shell (or outer) side of the hollow-fiber module and passed though the fiber wall
under a modest pressure difference (i.e. a pressure insufficient to cause disruption or
loss of integrity of the skin under “back-flush” conditions). During this step, enzyme is
accumulated in the porous substrate region of the fiber. Next, excess aqueous enzyme
solution is displaced from the shell side of the fiber bundle by flushing it with an
immiscible fluid such as air or the organic solvent. The module is then operated with
the organic solvent on the shell side and an aqueous solution in the lumen of the fiber
with a slight excess pressure on the shell side.When the enzyme becomes deactivated
and must be recharged, a positive pressure is applied to the aqueous solution on
the interior or lumen side of the fibers, thereby causing convective flow through the
membrane and displacement both of organic solvent from the shell side of themodule
as well as deactivated enzyme from the fiber walls.
2.6 Enzyme immobilization techniques in membrane reactor systems | 73
2.6.3 Cross linking
Immobilization of enzymes has been achieved by intermolecular cross-linking of the
protein, either to other protein molecules or to functional groups on a membrane ma-
trix. Cross-linking an enzyme to itself is both expensive and insufficient, as someof the
protein material will inevitably be acting mainly as a support, resulting in relatively
low enzymic activity. Generally, cross-linking is best used in conjunction with one of
the other methods. For instance, enzymemay first be adsorbed onmembrane exterior
or pore wall surfaces, subsequently to be anchored more positively by crosslinking
the adsorbed enzyme layer in place. Or, enzyme may first be encapsulated in poly-
acrylamide microgels and then cross-linked with glutaraldehyde to prevent leakage
out of the large pores in gel matrix.
2.6.4 Encapsulation
Since the second half of the 20th century, numerous efforts have been devoted to the
development of enzymemicroencapsulation techniques for various applications. The
examples of novel functional micro/nano-particles used for the microencapsulation
of enzymes can be seen in Fig. 2.13. In particular, membrane and microfludic devices
are considered to be very efficient tools for the production of size-controlled enzyme-
loaded emulsion droplets. Solid microparticles can be produced by secondary reac-
tions in the emulsifieddroplets, such as colloidal ormolecular self-assembly, polymer-
ization, gelation, and crystallization [98]. In the next sections the use of microfluidic
devices in the precise manufacture of enzyme-loaded microcapsules is explained in
more details.
2.6.4.1 Asymmetric vesicles
Pautot et al. [99] fabricated asymmetric vesicles,where the inner leafletwas composed
of POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and the outer leaflet com-
posed of POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine), or the reverse.
The flow focusing microfluidic device (FFMD) shown in Fig. 2.14 generates enzyme-
loaded triple emulsions in a single step [100]. The device consists of two concentric
tapered tubes nested within an outer square tube. The innermost fluid comprising of
aqueous solution of enzymes is pumped through the inner injection tube, the middle
fluid 2 pumped through the outer injection tube, and the middle fluid 1 flows through
the square tube outside the injection tubes. The outermost fluid is pumped through
the square tube from the opposite direction, and all fluids are forced through the
exit orifice formed at the entrance of the ‘collection tube’. This geometry results in
hydrodynamic focusing and rupturing of three coaxial jets, followed by the formation
of triple emulsion droplets containing enzyme solution surrounding by two phos-
74 | 2 Biocatalytic membrane reactors (BMR)
Liposomes Polymerosomes Microgels Colloidosomes
Asymmetric vesicles Thermo-responsive 
microcapsules
Nano-coated 
microgels
Carbon nanotubes
40° C
25° C
Diblock 
copolymer
Fig. 2.13: Examples of enzyme microcapsules.
pholipid shells. The volume of each phase can be tuned by changing the fluid flow
rates. Typical diameters of the exit orifice range from 20 to 200 μm, which allows
the drop size to be adjusted over a wide range. This triple emulsion is a template to
prepare asymmetric enzyme-loaded vesicle with two layers consisting of amphiphilic
molecules of different chemical structure.
2.6.4.2 Polymerosomes
The use of diblock copolymers to generate vesicles is an attractive strategy to cre-
ate new structures for enzyme encapsulation called polymerosomes, by analogy with
more traditional liposomes. The flexibility afforded by the use of diblock copolymers
significantly increases the control over the properties of polymerosomes. For example,
the membrane thickness can be controlled by varying the degree of polymerization
of the individual diblock molecules, whereas fluidity and permeability of the mem-
brane can be adjusted by changing the glass transition temperature of the hydropho-
bic block. Similarly, control over the nature of the individual polymer blocks can lead
to alternative mechanisms to trigger substrate loading and product release.
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Fig. 2.14: Generation of enzyme-loaded asymmetric vesicles in a flow focusing microfluidic device
(FFMD).
Amicrofluidic device depicted in Fig. 2.15 has been used to generate core/shellW/O/W
emulsionswith adiblock copolymer dissolved in themiddle hydrophobic fluid [4]. The
inner fluid is a buffer solution containing enzyme, and the outer phase is a mixture of
80% (v/v) glycerol in distilled water (Fig. 2.16). Glycerol was added to the outer fluid
to increase its viscosity, which improves the efficiency of the flow focusing. The mid-
dle phase is a volatile organic solvent; the evaporation of the organic solvent causes
the amphiphilic block copolymer poly(normal-butyl acrylate)-poly(acrylic acid) (PBA-
PAA) to self-assemble into layers on the concentric interfaces of the double emul-
sion droplets, forming an enzyme-loaded polymerosome. The PBA is the hydrophobic
block in the copolymermolecule,whereas thePAA is thehydrophilic block. It is critical
that the dissolvedmacromolecules aremostly unimers as opposed to larger aggregates
because such aggregates do not efficiently stabilize the inner droplets against coales-
cence with the outer phase. Using this microfluidic approach, it was also feasible to
prepare multicompartment polymersomes consisting of many internal compartments
starting fromW/O/W emulsions consisting of several inner drops [4].
76 | 2 Biocatalytic membrane reactors (BMR)
Injection tube Middle fluid Outer fluid
Outer tube Double emulsion droplet
Water + enzyme
Collection tube
Fig. 2.15: Fabrication of enzyme-loaded polymerosomes in a FFMD.
Inner fluid (water + enzyme)
Outer fluid (water + glycerol)
Micro-capsule
Microfluidic device
Evaporation
PBA
PAA
Middle fluid (PBA–PAA + THF/T)
Fig. 2.16: Production steps in the fabrication of enzyme-loaded polymerosomes.
2.6.4.3 Microgels
Hydrogels are cross-linked hydrophilic polymer networks that can absorb and hold
a large amount of water due to their hydrophilic nature [101]. They can be prepared
starting from monomers, prepolymers or existing hydrophilic polymers. A three-
dimensional gel network can be formed by chemical (covalent) crosslinking us-
ing crosslinkers such as glytaraldehyde and EDGA or by physical gelation, which
can involve a coil-to-helix transition (agarose and gelatine gels), hydrogen bonding,
stereocomplexation, hydrophobic interactions and charge interactions (calcium algi-
nate and chitosan-TPP gels). Microgels are hydrogel microspheres that can easily be
fabricated by charge interactions (ionotropic gelation). The main strategies for fab-
rication of microgels by ionotropic gelation are emulsification/internal gelation and
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atomization (or nozzle extrusion)/external gelation. In the internal gelation method,
emulsified droplets contain a gel-forming polymer (e.g. sodium alginate), enzyme and
a crosslinking agent in its inactive form (e.g. CaCO3) whereas the organic continuous
phase contains a species (e.g. H+) that diffuses into the droplets and triggers the
dissociation of the crosslinking agent. For a sodium alginate/CaCO3/H+ system:
CaCO3 + 2H+ 󳨀󳨀→ Ca2+ + H2O + CO2 ↑
The released Ca2+ ions bind to the guluronic residues of sodium alginate, crosslink-
ing the polymer and causing the gelation of the enzyme-loaded droplets [102]. This
process is reversible and the resultant beads are soluble in an aqueous solution con-
taining monovalent ions due to exchange of Ca2+ ions with non cross-linkable mono-
valent ions. Irreversible gelation can be achieved using alginate with phenol moieties
in the side chains (Alg-Ph), which can be synthesized through the conjugation re-
action of alginate and tyramin. Alg-Ph can be subjected to irreversible crosslinking
via oxidative C−C and C−O coupling of phenol moieties in the presence of hydrogen
peroxide and peroxidase. Sakai et al. [103] fabricated cell-loaded Alg-Phmicrogels us-
ing a co-flow microfluidic device. The disperse phase was Alg-Ph solution containing
cells and horseradish peroxidase (HRP); the continuous phasewas hydrogen peroxide
dissolved in liquid paraffin. Hydrogen peroxide can penetrate into alginate droplets
causing HPR-catalyzed crosslinking of alginate. Enzymatic crosslinking of Alg-Ph is a
suitable technique for screening for Glucose oxidase [104].
2.6.5 Segregation by membranes
In this method, enzymes are localized between hollow fiber membranes, either freely
suspendedor entrappedwithin a gel. If they are freely suspended, the enzyme suspen-
sion can be placed outside the fibers (within the shell) or in the fiber lumens. Zhang
et al. [89] immobilized carbonic anhydrase in PAA-AAm/HT nanocomposite hydro-
gel filled between hollow fibers. The reactor was designed for selective separation
of low concentration CO2 from gas streams. Zhang et al. [105] confined glucosidase
between two sheets of flat ultrafiltration membranes to convert maltose to isomalto-
oligosaccharides.
2.6.6 Covalent binding
The most frequently used enzyme insolubilization technique is the formation of co-
valent bonds between the enzyme and the membrane matrix. The binding reaction
must be performedunder conditions that donot cause a loss of enzymatic activity, and
the active site of the enzyme must be unaffected by the reagents used. The functional
groups of proteins suitable for covalent binding undermild conditions include: (i) the
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alpha amino groups of the chain and the epsilon amino groups of lysine and arginine;
(ii) the alpha carboxyl groupof the chain endand thebeta andgammacarboxyl groups
of aspartic and glutamic acids; (iii) the phenol ring of tyrosine; (iv) the thiol group of
cysteine; (v) the hydroxyl groups of serine and threonine; (vi) the imidazile group of
histidine; and (vii) the indole group of tryptophan. A small number of reactions have
been designed to couple with functional groups on the protein other than the amino
and phenolic residues. Aminoethyl cellulose has been coupled to the carboxylic acid
residues of enzymic protein in the presence of carbodiimide, and thiol residues of a
protein have been oxidatively coupled to the thiol groups of a cross-linked copoly-
mer of acrylamide and N-acryloyl-cystein. It is possible in some cases to increase the
number of reactive residues of an enzyme in order to increase the yield of insolubilized
enzyme and to provide alternative reaction sites to those essential for enzymic activity.
As with cross-linking, covalent bonding should provide stable, insolubilized enzyme
derivatives that do not leach enzyme into the surrounding solution. The wide vari-
ety of binding reactions and membranes with functional groups capable of covalent
coupling, or being activated to give such groups, makes this a generally applicable
method of immobilization, even if very little is known about the protein structure or
active site of the enzyme to be coupled.
Fig. 2.17 illustrates modification steps used for covalent immobilization of the en-
zyme pig liver esterase on the nylon (polyamide)membrane: (a) Epoxy terminal group.
The membrane is modified by recirculation of a 1M solution of 1,4-butanediol digly-
cidyl ether in borate buffer at pH 9; (b) Imidazol terminal group. 0.4M solution of
carbonyl diimidazole (CDI) is re-circulated through themodule for 30min. After wash-
ing with acetonitrile and water, a 1M solution of 1,6-hexanediamine in a borate buffer
at pH 8.5 is re-circulated through the module for 24 h. The CDI reaction step is then
repeated; (c)Amino terminal group. The procedure is the same as the one to obtain the
imidazol terminal group, without the final CDI reaction step; (d) Carboxylic acid termi-
nal group. A solution of glutaraldehyde and 0.1M cyanoborohydride in borate buffer
at pH 9.4 is recirculated through the module for 4 h. After washing with fresh buffer,
a 0.4M solution of aminocaproic acid and 0.1M cyanoborohydride in borate buffer is
re-circulated overnight [12].
Belleville et al. [106] and Lozano et al. [107, 108] have developed the enzyme
immobillization technique based on covalent binding of enzymes on polymer-coated
porous ceramic membranes. The method involves three main steps illustrated in
Fig. 2.18. First, the inner surface of zirconia/α-alumina membrane tube is coated
with an ultra-thin gel layer obtained during cross-flow filtration of an inert protein
solution such as gelatin [109]. The dynamic protein layer is then activated with a
cross-linking agent (glutaraldhehyde) and finally, the activated layer is brought into
contact with the enzyme solution in order to covalently bind the enzyme. Using this
procedure, the enzyme α-chymotrypsin has been immobilized onto a gelatin-zirconia
or gelatin-α-alumina dynamic membrane and used for the organic-phase synthesis
of the analgesic dipeptide, kyotorphin, from N-benzoyl-L-tyrosine ethyl ester and
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Fig. 2.17: Modification steps used for covalent immobilization of the enzyme pig liver esterase on
nylon membrane: (a) epoxy terminal group; (b) imidazol terminal group; (c) amino terminal group;
(d) carboxylic acid terminal group [12].
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Fig. 2.18: Procedure for preparing catalytic membrane by the covalent attachment of the enzyme
onto α-alumina support coated by hydrophilic polymers [110].
L-argininamide [107]. The hydrophilic nature of the gelatin coating layer provided
good protection of the enzyme structure against deactivation by a direct contact with
the organic solvent.
The method for preparing enzyme ceramic membrane has been improved by us-
ing polyethyleneimine (PEI) as a coating agent with the higher content of free primary
amino groups, which allowed an increase in the number of potential covalent links
for the enzyme attachment. The best results were obtained with a 50% mixture of
gelatin and PEI [110]. The application of this procedure to prepare immobilized Can-
dida antarctica lipase B for the synthesis of butyl butyrate from vinyl butyrate and
1-butanol and butyl laurate from butyl acetate and lauric acid in supercritical carbon
dioxide (SC CO2) and different organic solvents (acetonitrile, acetone and hexane) has
been demonstrated by Lozano et al. [108, 111], Gumi et al. [112] and Mori et al. [113].
Contrary to the applications where SC CO2 acts as a solvent, Pomier et al. [114, 115]
have developed another process in which SC CO2 was mixed together with a highly
viscous oil to obtain a heterogeneous mixture of reduced viscosity. The mixture was
then brought into contact with the enzymatic membrane to conduct esterification re-
actions on oil. The main advantage is to avoid the use of high temperatures and the
addition of organic solvents. This process has been tested through the lipase-catalyzed
interesterification reaction of castor oil triglycerides (TG) with methyl oleate:
Castor oil TG +methyloleate methyl ricinoleate + TG
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2.7 Laminated (multilayer) enzyme membrane reactors
2.7.1 Concept
Matson and Quinn [116, 117] have developed a laminated (multi-sandwiched) mem-
brane reactor that enables a catalytic reaction with simultaneous product separation
and recovery. Fig. 2.19 shows a cross section of one such two-layer composite mem-
brane capable of product separation and enrichment. It consists of permselective and
catalytic membrane layers contacted on one side with a feed mixture of reactant (R)
and inert material (I); the other membrane surface contacts a sweep stream (S), the
purpose of which is to carry the product (P) out of the reactor. The permselective film
permits reactant to diffuse into the catalytic membrane layer, but it is impermeable
to at least one reaction product (e.g. product P in Fig. 2.19 (a) and (b)) preventing its
backdiffusion into the feed stream.
F ( R + I )
R X P B+
Permselective layer
Catalytic layer
(a)
S
F ( R + I )
R X P
Permselective layer
Catalytic layer
(b)
S
Fig. 2.19: Schematic view of the two-layer com-
posite membrane showing the diffusion and
interaction of materials during a single stage cat-
alytic reaction. Reaction scheme (a): R 󳨀󳨀󳨀→ P + B;
Reaction scheme (b): R 󳨀󳨀󳨀→ P.
For carrying out a multiple catalytic reaction, the three-layer composite membrane
shown in Fig. 2.20 should be used, with its catalytic membrane layer being sand-
wiched between the two permselective layers. The catalytic membrane contains two
different catalysts (X and Y). The permselective membrane layer 1 should be sub-
stantially impermeable at least to the intermediate precursor (A) of the desired end
product (P) and preferably to the inert component, so as to substantially maintain
the inert component on the feed stream side of the membrane. Likewise, when one
or more undesired reaction byproducts are formed in the reaction, the permselec-
tive membrane layer 1 should be preferably permeable to such byproducts, so as to
ensure their substantial diffusion into the feed stream and thus separation from the
desired end product. In practice, the permselective membrane layers are immobilized
liquid membranes (ILMs), ion exchange membranes (IEMs), and facilitated transport
membranes. Particularly suitable membranes for this purpose are immobilized liquid
82 | 2 Biocatalytic membrane reactors (BMR)
membranes consisting of a water-immiscible solvent for the particular reactant being
employed, held by capillarity in a microporous hydrophobic support membrane.
ILM’s and IEM’s are particularly suitable for reactions which form charged products
from electrically neutral reactants; the difference in solubilities of electrolytes and
non-electrolytes in organic solvents can be exploited to form ILM’s of high selectivity,
and Donnan exclusion of an electrolyte from an IEM is a second basis for selectivity.
In addition, a chemical reaction can introduce or remove functional groups, with the
result that a highly selective facilitated or coupled transport system may be available
either for the reactant or product.
F ( R + I )
R X A P
Y
Permselective layer 1
Catalytic layer
Permselective layer 2
I
SS+P
Fig. 2.20: Schematic view of the three-layer
composite membrane during a two stage cat-
alytic conversion reaction catalyzed by X and Y
catalysts.
Another feature of this membrane reactor is its ability to enrich the product, i.e. to
deliver product at a concentration higher than that of the reactant in the feed stream.
If the permselective film is essentially impermeable to the product, the concentration
of this component in the exiting product stream will be inversely proportional to the
product stream flow rate. Hence, high degrees of product enrichment can be realized
by operating the reactor at high feed-to-product stream flow rate ratios. Typically, the
feed stream flow rate will be adjusted to achieve the desired conversion; the product
stream flow rate then controls the degree of product enrichment [1]. The high feed-to-
product streamflow rate ratios automatically ensure high fractional recoveries of inert
in the exiting feed stream. Even in the limiting case where the membrane is infinitely
permeable to the inert (so that the concentrations of inert on both sides of the mem-
brane are the same), the molar ratio of inert recovered in the exiting feed stream to
that carried away with the sweep fluid is approximately equal to the flow rate ratio.
Neither product separation nor enrichment can be accomplished simultaneously
with chemical conversion in conventional reactors employing catalyst particles, be-
cause all components exit the reactor via a common stream, and product enrichment
is prohibited by the material balance. On the other hand, the laminated membrane
reactor is an integrated multifunctional device capable of performing these three op-
erations of catalysis, separation and concentration simultaneously rather than sepa-
rately in three different pieces of equipment, as shown in Fig. 2.21.
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Fig. 2.21: Comparison of (a) laminated membrane reactor, in which catalysis, separation and enrich-
ment are integrated within a single device, and (b) conventional process, in which catalytic reaction,
product separation and product recovery are accomplished in three separate devices (R = reactant,
I = inert, P = product).
2.7.2 Application
The ability of α-chymotrypsin to hydrolyse ester derivates of the aromatic L-amino
acids and other related compounds while leaving the D-enantiomers unconverted
forms the basis for the preparative resolution of these compounds. Enzymatic res-
olution based on the esterase function of chymotrypsin has been demonstrated for
tyrosine [118], phenylalanine [119], tryptophan [120], aspartame [121], dopa [122], and
many other related compounds [123]. One example of substrate capable of being
resolved by α-chymotrypsin is N-acetyl tyrosine ethyl ester (ATEE):
CH2CHCOOC2H5 + H2O
α–ChT
pH 7.8
HO
NHCOCH3
D,L – ESTER (ATEE) L – ACID
CH2CHCOO  + H  + C2H5OH + D-ESTERHO
NHCOCH3
The application of a laminated membrane reactor to the optical resolution of amino
acid ester derivates is illustrated in Fig. 2.22 [117]. The reactor consists of a two-layer
sandwich of a chymotripsin enzyme membrane in intimate contact with an immobi-
lized liquid membrane (ILM). The enzyme membrane consists of chymotrypsin co-
valently bound to MF mixed cellulose ester membrane. ILM should be permeable to
electrically neutral species such as esters, but impermeable to charged species such as
the dissociated L-acid. The ILM used byMatson andQuinn [117] consisted of amicrop-
orous, hydrophobic polytetrafluoroethylene (PTFE) support membrane impregnated
with decanol that was trapped within the pores by capillary action. Such amembrane
combines the desirable permeation properties of the liquid phase (e.g. high ester sol-
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Fig. 2.22: Application of laminated enzyme membrane reactor to the resolution of amino acids:
(a) membrane function and (b) reaction operation [117]. The solid arrow lines represent the preferen-
tial flux directions.
ubility and diffusivity) with the mechanical properties and geometry of the porous
solid support. Both esters dissolve easily into the ILM film and diffuse to the enzyme
membrane where only L-ester is converted to its acid form, L-acid. Since the L-acid is
charged at the pH at which the enzyme operates, it cannot dissolve into the ILM and
diffuse back into the feed stream but is forced to migrate into the sweep buffer. By
operating the reactor at high feed-to-product flow rate ratios, most of the inert D-ester
will be recovered in the exiting feed stream and the L-acid will be removed at a higher
concentration than that of the L-ester in the racemic feed mixture. In fact, optical res-
olution occurs when the reactor of Fig. 2.22 is operated to give high L-ester conversion
(i.e. at a large dimensionless space time Φ) and high L-acid enrichment (i.e. at a large
flow rate ratio ϕ). The former condition results in an exiting feed stream that contains
primarily D-ester that has been stripped of most of the L-ester, whereas the latter con-
dition ensures a high ratio of L- to D-acid in the product stream.
The laminated membrane reactor was tested for separation of optical isomers
froma racemic feedmixture composed of 2mMD,L-ATEE in 0.10Mphosphate buffer at
pH 7.8 [117]. The separation results summarized in Fig. 2.23 (a) demonstrate the ability
of themultilayermembrane reactor to accomplish optical resolution at high efficiency.
Still higher feed and product stream optical purities can be attained by increasing the
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membrane reactor space time Φ and the flow rate ratio θ (VF/VP), respectively. The
dimensionless membrane reactor space time Φ is given by PA/VF, where A is the
membrane area, VF is the feed stream flow rate and P is the ILM permeability to the
reactant (L-ester): P = KDε/(δτ), where K is the dimensionless distribution coefficient
of the reactant betweendecanol and the feed stream,D is the diffusivity of the reactant
in decanol and ε, δ, and τ are the porosity, thickness and tortuosity of the support
membrane, respectively. The degree of enantiomeric purity of product streams was
estimated by their enantiomeric excess: ee = (XD −XL)/(XD +XL) = 2XD −1, where XD
and XL are the mole fraction of D- and L-isomer in the exit stream, respectively. At the
operating conditions shown in Fig. 2.23 (a), both product streams contain one of the
two enantiomers at optical purities of 86%, whereas the optical purity of the racemic
feed mixture was 0%.
Racemic feed
1 mM L-ESTER
1 mM D-ESTER
Feed exit: XD = 0.93, ee = 86%
Product: XD = 0.93, ee = 86%
Φ = 6.5
θ = 1310.6 mM L-ESTER
0.8 mM D-ESTER
(a)
0.07 mM L-ESTER
0.92 mM D-ESTER
Sweep
buffer
Product
Feed exit
1.01 ml/min
5 mM bPG
50 mM TBA
pH 6.5
Removal of bPG = 0.49
Product enrichment factor = 4.8
FEED
θ = 10.10.1 ml/min
0.1 M Boric Acid
0.05 M
Phosphate
pH 8.5
(b)
2.55 mM bPG
24 mM 6-APA
Fig. 2.23: Typical performance of laminated enzyme membrane reactor in: (a) amino acid resolution
[117]; and (b) enzymatic deacetylation of benzyl penicillin [124].
The laminated membrane reactor was also used to convert benzylpenicillin (bPG) to
6-aminopenicillanic acid (6-APA) and phenylacetic acid (PhAA) by penicillin acylase
(PA) [124]:
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The transport of negatively charged bPG (at neutral pH) through an apolar ILM,
(consisting of a porous Teflon membrane impregnated by decanol) was promoted by
the formation of a neutral complex between the bPG anion and tetrabutylammonium
cation present in the feed stream [125]. This coupling significantly increased the dis-
tribution of bPG into the apolar membrane. The product 6-APA could not dissolve to
any great extent in the ILM due to a higher pH in the product stream andwas collected
in the sweep buffer at high concentrations (Fig. 2.23 (b)).
Laminated enzyme membrane reactor technology suffers from two limitations:
it is relatively complicated and does not utilize convective transport which is faster
than molecular diffusion [126]. To extend and simplify this concept, Matson [97] has
developedmultiphase membrane reactors in which a single enzymemembrane is po-
sitioned between aqueous and organic flow streams. This approach is discussed in the
following section.
2.8 Biphasic (multiphase) membrane bioreactors
2.8.1 Concept
Instead of trapping the organic phase in one membrane (ILM) and using a bilayer
membrane sandwich to separate two aqueous solutions, in biphasic (multiphase)
membrane reactors a single hydrophilic, enzyme-activated porous membrane is used
to separate immiscible aqueous and organic streams [97, 127, 128]. By virtue of the
hydrophilicity of the membrane and the slight organic-to-aqueous-phase pressure
difference imposed across the membrane, the aqueous/organic interface is fixed at
that side of the membrane that is in contact with the organic stream. A poorly water-
soluble reactant (R) partitions into the membrane and is enzymatically converted to
water-soluble product (P), which subsequently diffuses out into the aqueous stream
(Fig. 2.24). The enzyme-activated membrane serves as a high-surface-area organic/
aqueous phase contactor, as an organic/aqueous phase separator, and as an inter-
facial biocatalyst. By placing hydrophilic hollow fiber membranes at the interface
between the two immiscible phases (Fig. 2.25 (a)), it is possible to provide a large
organic/aqueous contact area without the necessity of dispersing one immiscible
phase within the other, as in conventional emulsion-based multiphase systems. By
controlling flow rate ratios of the aqueous and organic streams, it is possible to obtain
a product at a concentration higher than the concentration of its organic-phase pre-
cursor in the feed stream, like in previously discussed laminated membrane reactors.
Conventionally, enzyme-catalyzed conversions of sparingly water-soluble sub-
strates are conducted in a two-phase system in which free enzyme is dissolved in a
continuous, aqueous phase and substrate (and often products) are present in a sep-
arate, immiscible organic phase dispersed within the aqueous phase [129]. A novel
approach in emulsion membrane reactor systems is the dispersion of the organic
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Fig. 2.24: Schematic, cross-sectional view
of the enzyme-activated membrane in a multi-
phase membrane reactor process [134].
phase within the aqueous phase using membrane emulsification [130, 131]. Alter-
natively, the aqueous phase may be dispersed within a continuous organic phase
forming a water-in-oil emulsion (W/O). Another approach to the use of enzymes
in conjunction with water-insoluble substrates involves conducting the reaction in
substantially water-free organic reaction media [132] or in the presence of reversed
micelles containing entrapped enzymes [133]. While some limited success has been
achieved with these approaches, they are not very general. In particular, many en-
zymes are altogether inactive in neat or water-saturated organic solvents, and those
that do retain some activity often exhibit altered selectivity or reduced stability.
If it is desirable to immobilize the enzyme on a high-surface-area support in order
to facilitate its recovery and reuse, a triphasic reaction scheme may be employed
(Fig. 2.25 (b)). In three-phase systems, the water-insoluble substrate is supplied in
an organic phase (with or without added organic solvent), with the organic phase
being dispersed in a continuous aqueous phase. The enzyme is then immobilized
within a third, solid phase (porous particles), and the three phases are contacted in a
stirred vessel or packed bed. Excessive aqueous phase mass transfer resistances and
phase separation and product recovery problems characterize this approach. Using
hollow fiber membranes to separate the aqueous and organic streams, the substrate
is brought close to the catalyst reducing diffusion limitations.
Enzymes are usually entrapped within a spongy fiber wall, as illustrated in
Fig. 2.26. The interior or luminal fiber surface consists of an enzyme-retentive skin
with a nominal molecular-weight cut-off of typically about 30 kDa, while the exterior
fiber surface is open and readily penetrated by enzymes [91]. This asymmetric struc-
ture immobilizes the enzyme by localizing it between two barriers: (i) the enzyme-
impermeable interior skin; and (ii) the aqueous/organic interface maintained at the
exterior surface of the hollow fiber. The size of the enzyme prevents it from diffusing
across the skin, while the low organic-phase solubility of the enzyme prevents it from
being carried away by the organic stream. Enzymes are loaded into the porous fiber
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Fig. 2.25: Comparison of multiphase immobilised enzyme reactors: (a) hollow-fiber dispersion-free
membrane reactor; (b) conventional dispersion-based reactor [91].
walls by ultrafiltering aqueous enzyme solution in the shell-to-lumen direction for
several hours; the UF skin at the luminal surface of the fiber retains the enzymewithin
the interior. Once the enzyme is in place, the external aqueous phase is replacedby the
organic phase feed stream. The degraded enzyme can easily be replaced by reversing
the pressure differential, backflushing, and then reloading. Alternative approaches
rely on the formation of dynamic enzyme-gel-polarized membranes atop the surface
of ultrafiltration membranes [134] or the covalent attachment [12].
2.8.2 Application
Multiphase membrane reactors are appropriate for enzymatic conversions that in-
volve sparingly water-soluble substrate or product. An example is the separation
of racemic mixtures on the preparative scale, where the reactants are often spar-
ingly soluble in aqueous solution. Since enzymes generally operate in aqueous
solutions and not organic solvents, it has proven difficult to facilitate the enzyme-
catalyzed bioconversion and subsequent separation of poorly water-soluble optical
isomers. Multiphase (biphasic) membrane reactors offer many advantages in man-
aging these sorts of reactions [127, 128, 134]. Typically, the membrane immobilized
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Fig. 2.26: Reversible enzyme containment in multiphase enzyme hollow-fiber membrane reactor.
enzyme preferentially converts one reactive stereoisomer in a racemic (R and S) feed
mixture of water-insoluble feed isomers to a water-soluble product isomer of altered
chemical composition. Enzymes that are particularly useful for this conversion are
hydrolytic enzymes such as lipases, carboxyl esterases and amidases. The water-
soluble product isomer exits the reactor via the aqueous stream, while the unreactive
water-insoluble reactant isomer (S or R) in the racemic feed leaves the reactor via the
organic stream. The overall result is that these two species with different stereocon-
figurations will be partially isolated from one another. The example of this method
is the lipase-catalyzed optical resolution of racemic feed mixtures of esters such as
methyl ester of 4-methoxy-3-phenylglycidic acid (MMPG), a chiral intermediate used
in the production of diltiazem [91, 135], naproxenmethyl ester [136, 137], cyanomethyl-
[2-(4-isobutylphenyl)propionate] [138], 2-hydroxy octanoic acidmethyl and butyl ester
[16], 1-phenylethyl acetate and 1-phenyl-1-propyl acetate [90, 139], 2-ethoxyethyl-ibu-
profen ester [96], and glycidyl butyrate [139]. In this case, a racemic mixture of esters
dissolved in an organic solvent is stereospecifically hydrolyzed by the enzyme, and
the optically enriched organic acid (and water-soluble alcohol co-product) thereby
produced are removed by an aqueous stream, as shown in Fig. 2.27.
The net result is that a mixture of R and S optical isomers is separated into two
streams; the organic-phase stream contains the unconverted lipophilic isomer present
in the original feed stream,while the aqueous stream contains thewater-soluble enzy-
matic reaction product possessing the opposite stereochemical configuration. Overall
yields of the desired enantiomer may be further enhanced by racemization of the ma-
terial in one of the exiting streams, followed by its recycle to the inlet of the resolution
process as shown in Fig. 2.28.
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Fig. 2.27: Schematic representation of a method for the resolution of a racemic mixture of organic-
soluble esters (chiral center on acid moiety).
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Fig. 2.28: Example of an integrated resolution/racemisation/recycle process for the production of a
singly optically purified product, in which the undesired isomers are racemised and recycled inter-
nal to the process with the net result that only material of the desired stereochemical configuration
is produced [134].
In the same way, the multiphase enzyme membrane reactor process can produce and
concurrently isolate a water-soluble organic product stereoisomer in the aqueous pro-
cess stream exiting a multiphase membrane reactor from an organic-soluble achiral
precursor that remains in the organic process stream [134]. Achiral precursors which
can be biotransformed into chiral products include hydantoins and amino nitrile
compounds, which can stereoselectively be converted into such valuable products
as amino acids (e.g. D-amino acids and methyl dopa) and amino amides. Another
application of this type of multiphasemembrane reactor process is the stereoselective
hydrolysis of water-insoluble, symmetric diesters to chiral, water-soluble acid ester
products, as catalyzed by pig liver esterase. In this application, the achiral diester
reactant is fed to the reactor in the organic phase, and the chiral and optically pu-
rified acid ester product is withdrawn in the aqueous phase on the opposite side
of the membrane [134]. An example is the enantioselective hydrolysis of the sub-
strate cis-1,2-dimethylcyclohex-4-ene-1,2-dicarboxylate (cis-DE) to the chiral product
of pharmaceutical interest, (1S,2R)-cyclohex-4-ene-1,2-dicarboxylic acid monomethyl
ester ((1S,2R)-ME)):Note 8: Un-
balanced
parentheses?
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This conversion has been investigated by Sousa et al. [12] using a biphasic hollow
fiber membrane reactor containing the immobilized enzyme pig liver esterase. Four
covalent attachment techniques (using epoxy, imidazol, amino and carboxylic acid
terminal groups) were tested to bind the enzyme to microporous nylon membranes in
addition to physical entrapment technique. The physical entrapment method led to
the highest retention of enzymatic activity over a prolonged period of time.
The feed stream inmultiphasemembrane reactor processesmay either be organic
or aqueous. Fig. 2.29 depicts a process for the resolution of a racemic feed mixture of
water-soluble acids and the attendant production of optically purified aqueous acid
and organic ester streams. In this process, the mixture is fed in an aqueous solution
to one side of an enzyme-activated membrane, and one isomeric component of the
racemic acid mixture is stereoselectively combined with a water-soluble alcohol in an
enzyme-catalyzed esterification reaction, and the optically enriched ester product is
removed by an organic process stream consisting of a water-immiscible organic sol-
vent for the product ester which is fed onto the opposite side of the membrane.
Enzyme-activated membrane
Racemic (R & S)
R1COOH + R2OH
Optically enriched 
(S or R) R1COOH
Optically 
enriched (R or S)
R1COOR2
Organic stream
Fig. 2.29: Schematic representation of a method for the resolution of a racemic mixture of water-
soluble organic acids fed in an aqueous feed stream [134].
The multiphase enzyme membrane reactors have also been extensively investigated
as an alternative method for the enzymatic hydrolysis of triglycerides (e.g. olive oil
and butter oil) to fatty acids [94, 140–149]. Hoq et al. [94] have investigated the lipase-
catalyzed hydrolysis of olive oil by lipase using hydrophobic polypropylene hollow
fiber membrane. Olive oil was fed inside the fibers, a buffer solution containing
18% glycerol added as a stabilizer was fed outside of the fibers and the enzyme
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Fig. 2.30: Schematic representation of the enzymatic olive oil conversion in a biphasic hollow fiber
bioreactor. Adapted from [94].
was adsorbed on the membrane/aqueous phase interface (Fig. 2.30). Fatty acids were
released in the hydrophobic phase and glycerin in the hydrophilic phase.
2.9 Phase transfer catalysis in multiphase membrane reactors
2.9.1 Concept
Although the examples described above are for enzymatic catalysis with membrane
systems, the same approaches can be extended to non-biological catalytic reactions.
One example of this is the use of membrane contactors for phase-transfer catalysis
(PTC) [150, 151]. PTC has been widely used in reactions that occur in an organic media
where two or more reactants are involved and all but one of these is soluble in the or-
ganic phase. The one insoluble reactant is usually an anion dissolved in an aqueous
phase. In the absence of the phase transfer catalyst (PTC), the solubility of the anion
in the organic phase is generally so small that negligible reaction rates are observed.
However, the presence of a PTC in the reaction mixture promotes the transfer of the
reacting anion into the organic phase, thus allowing the reaction to proceed at a sig-
nificantly higher rate.
The mechanism of a phase-transfer catalyzed ion exchange reaction is shown in
Fig. 2.31. As illustrated, the catalyst Q+ extracts the aqueous phase reactant Y– into
the organic phase, where the reaction takes place between the complex Q+Y– and the
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reactant RX. The products of this reaction are RY and the complex Q+X– . Reaction
conditions are most favorable when extraction of Y– is highly favored over extrac-
tion of X– since this will cause the less soluble complex Q+X– to be returned to the
aqueous phase. This permits Q+ to be regenerated and rendered capable of extracting
more Y– . Typical phase-transfer catalysts Q+ are quaternary ammonium or phospho-
nium cations, or cyclic polyethers complexed with small cations.
RX + Q+Y–org Q+X–org + RY
organic phase interface
aqueous phase
M+X– + Q+Y–org Q+X–aq + M+Y–
RX RY
M+X– M+Y–
Q+Y–org
Q+Y–aq Q+X–aq
Q+X–org
Fig. 2.31: Mechanism of anion displacement reaction in phase transfer catalyzed reaction system.
A key criterion required in a PTC reactor is high interfacial area with little emulsi-
fication to enable easy phase separation. The use of membrane modules for a PTC
reaction fulfills this criterion as well as offering the advantages of high operating flex-
ibility andeasy scaleup. Conventionally, PCT is conducted indispersed-phase systems
based on the continualmaking andbreaking of emulsions. A number of problemsmay
arise in these systems such as phase separation and entrainment of one phase into
the other, which results in reduced product purity and loss of expensive product and
phase transfer catalyst. Another disadvantage of conducting PTC in dispersed-phase
systems is its operating inflexibility. Whereas in conventional PTC the interfacial area
between the organic and aqueous phases depends on the relative volumes of the two
liquid phases (as well as on other operating parameters such as the degree of agita-
tion), in membrane PTC the area of the aqueous/organic interface is fixed and equal
to the membrane area. For this reason, membrane PTC reactors can efficiently be op-
erated at more extreme volumetric phase or flow rate ratios than is the case in the
absence of a membrane.
2.9.2 Application
Phase-transfer catalyzed reactions include nucleophilic substitution reactions, car-
bene formation, alkylations and alkoxylations, oxidations and reductions, and con-
densation, elimination and addition reactions. Examples of such reactions are the
formation of ring compounds from straight-chain halocarbons, esters from acids and
ethers from alcohols; the synthesis of alkylchlorides and other alkyl halides by anion
displacement; the alkylation of carbanions; and the oxidation of olefins to carboxylic
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acids [152]. Grigoropoulou et al. [153] have demonstrated the feasibility of the selective
oxidation of benzyl alcohols using tetrabutylammonium as a phase transfer catalyst
in a flat sheet diaphragm cell containing a porous PTFE membrane to separate the
aqueous and organic phase.
Matson and Stanley [150] have employed a flat sheet membrane reactor shown in
Fig. 2.32 to conduct a phase phase-transfer catalyzed conversion of bromooctane to
iodoctane in the organic solvent chlorobenzene. The reactor was fashioned from two
aluminum blocks and a very shallow flow channel (0.05 × 10 × 20 cm3) was cut into
each block. The flowing streams were isolated by bolting the two blocks together with
a hydrophobic PTFEmembrane sandwiched in between. The aqueous streamwas run
at a higher pressure than the organic stream in order to maintain a stable interface at
the surface of the hydrophobic membrane adjacent to the aqueous stream. Because
of this pressure drop, the membrane was supported by a porous stainless steel screen
fastened to the bottom of the organic stream flow channel. Bromooctane in the or-
ganic solvent chlorobenzene was reacted with aqueous iodide to form iodoctane in
chlorobenzene and aqueous bromide ion. The iodide anion was transferred from the
aqueous to organic phase using tetrabutylammonium cation as a phase transfer cat-
alyst. 33% conversion was observed in steady state at 3.1ml/h. No entrainment of
chlorobenzene in the aqueous effluent could be detected visually and no water was
observed in the chlorobenzene effluent after 72 h of operation without interruption.
Bromooctane + I– → lodooctane + Br–
Organic solvent: chlorobenzene
Catalyst: Tetrabutylammonium iodide 
Aqueous
Organic
Fig. 2.32: Phase Transfer Catalyst membrane reactor system developed by Matson and Stanley [150].
2.10 Conclusions
The technologies and applications reviewed in this chapter document the growing
interest in the integration of biochemical reactions into various membrane systems.
Membrane bioreactors provide a promising technology for a variety of biochemical
conversion/separation processes. It is a consequence of the fact that membrane bio-
reactors canprovidemany benefits over conventional reactor designs, such as integra-
tion of separation and purification steps with catalytic reactions, much higher order
of structural and functional organization, a high degree of control over the fluxes
of reactants and products to and from a suspended or membrane-immobilized bio-
References | 95
catalyst, etc. In addition to being a separation barrier, membranes can also serve to
create a dispersion-free contact of immiscible process streams. The examples of this
approach are membrane aeration bioreactors and biphasic aqueous/organic systems.
In biphasic systems, two immiscible liquid phases are contacted across a membrane
without the necessity of dispersing one immiscible phase within the other. The con-
cept has applications in enzymatic conversions of sparingly water-soluble substrates
to water-soluble products and in phase transfer catalysis. The most common enzyme
immobilization techniques are reviewed including a novel technique of immobiliza-
tion of enzymes onto polymer-coated inorganic membranes and the application of
these hybrid membranes in the bioreactors operating with a supercritical fluid.
Novel enzymemicrocapsules based on advanced functional micro/nano-material
have been also discussed, with a special emphasis onmicrofluidic preparation routes.
It was concluded that microfluidic and membrane devices afford the production of
highly controllable enzyme-loaded microcapsules, whose semipermeable walls can
be composed of asymmetric lipid bilayers, colloidal particles, amphiphilic diblock
copolymers and polyelectrolyte multilayers.
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